Skip to main content
. 2018 Aug 28;11:447–458. doi: 10.2147/DMSO.S169925

Table 2.

Characteristics of the subjects at baseline

Characteristics Placebo group (n=38) KPE group (n=38)
Age (years) 49.5±9.3 50.2±8.0
Height (cm) 159.45±6.28 159.0±8.28
Body weight (kg) 69.01±5.44 68.81±7.21
BMI (kg/m2) 27.14±1.47 27.19±1.42
Waist circumference (cm) 94.27±5.67 94.38±5.51
SBP (mmHg) 125.0±14.9 127.0±13.1
DBP (mmHg) 76.1±10.8 75.9±9.1
HR (bpm) 68.0±10.3 66.7±7.4
Abdominal fat area
 Visceral (cm2) 90.30±19.45 90.23±19.22
 Subcutaneous (cm2) 258.13±72.16 257.30±69.43
 Total (cm2) 348.43±71.63 347.54±70.95
Cholesterol
 Total-Cho (mg/dL) 221.4±28.4 219.7±26.4
 HDL-Cho (mg/dL) 71.4±14.2 68.8±15.5
 LDL-Cho (mg/dL) 139.0±29.3 137.7±25.4

Notes: Values are presented as mean±SD. There were no significant differences between the groups.

Abbreviations: BMI, body mass index; bpm, beats per minute; Cho, cholesterol; DBP, diastolic blood pressure; HDL, high-density lipoprotein; HR, heart rate; KPE, Kaempferia parviflora extract; LDL, low-density lipoprotein; SBP, systolic blood pressure.